1. Home
  2. HCAT vs SGHT Comparison

HCAT vs SGHT Comparison

Compare HCAT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • SGHT
  • Stock Information
  • Founded
  • HCAT 2008
  • SGHT 2011
  • Country
  • HCAT United States
  • SGHT United States
  • Employees
  • HCAT N/A
  • SGHT N/A
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • SGHT Medical Specialities
  • Sector
  • HCAT Technology
  • SGHT Health Care
  • Exchange
  • HCAT Nasdaq
  • SGHT Nasdaq
  • Market Cap
  • HCAT 464.4M
  • SGHT 304.4M
  • IPO Year
  • HCAT 2019
  • SGHT 2021
  • Fundamental
  • Price
  • HCAT $5.90
  • SGHT $3.15
  • Analyst Decision
  • HCAT Buy
  • SGHT Buy
  • Analyst Count
  • HCAT 11
  • SGHT 7
  • Target Price
  • HCAT $11.45
  • SGHT $6.27
  • AVG Volume (30 Days)
  • HCAT 551.9K
  • SGHT 213.7K
  • Earning Date
  • HCAT 02-20-2025
  • SGHT 03-06-2025
  • Dividend Yield
  • HCAT N/A
  • SGHT N/A
  • EPS Growth
  • HCAT N/A
  • SGHT N/A
  • EPS
  • HCAT N/A
  • SGHT N/A
  • Revenue
  • HCAT $302,062,000.00
  • SGHT $79,543,000.00
  • Revenue This Year
  • HCAT $6.04
  • SGHT $2.13
  • Revenue Next Year
  • HCAT $11.19
  • SGHT $7.99
  • P/E Ratio
  • HCAT N/A
  • SGHT N/A
  • Revenue Growth
  • HCAT 4.15
  • SGHT N/A
  • 52 Week Low
  • HCAT $5.42
  • SGHT $3.15
  • 52 Week High
  • HCAT $11.06
  • SGHT $8.45
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 28.81
  • SGHT 30.03
  • Support Level
  • HCAT $6.83
  • SGHT $3.46
  • Resistance Level
  • HCAT $7.65
  • SGHT $3.73
  • Average True Range (ATR)
  • HCAT 0.44
  • SGHT 0.14
  • MACD
  • HCAT -0.08
  • SGHT -0.01
  • Stochastic Oscillator
  • HCAT 3.31
  • SGHT 0.00

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Share on Social Networks: